Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

Summary

The objective of this trial is to compare an individually optimized dose of the lisuride TTS patch against placebo and against an individually optimized dose of oral ropinirole (active- and placebo-controlled design) in idiopathic and uremic RLS patients with regard to efficacy, safety, and quality of life.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications